Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Tourmaline Bio Inc's price target?
Analysts forecast that Tourmaline Bio Inc's price target is USD 48.00, with the highest forecast at USD 48.00 and the lowest forecast at USD 48.00.
How have Tourmaline Bio IncTRML's recent earnings per share performed?
The market expectation was USD -0.90, while Tourmaline Bio IncTRML's earnings per share (EPS) for the previous quarter was USD -0.89. EPS for the next quarter is expected at USD -0.95.